Table 2.
PANSS scores after 12-week risperidone treatment by sex.
Baseline | 12-Week | Sex Sex × Time | ||||
---|---|---|---|---|---|---|
Male | Female | Male | Female | p | p | |
Clinical symptoms (PANSS score), mean ± standard deviation | ||||||
P score | 21.3 ± 6.3 | 23.1 ± 6.6 | 12.1 ± 4.7 | 11.8 ± 4.7 | 0.27 | 0.021 |
N score | 18.9 ± 7.1 | 18.5 ± 6.7 | 14.8 ± 5.8 | 13.5 ± 5.4 | 0.26 | 0.31 |
G score | 35.2 ± 9.7 | 36.5 ± 10.1 | 25.6 ± 6.8 | 24.7 ± 5.5 | 0.84 | 0.11 |
Total score | 75.4 ± 17.5 | 77.7 ± 18.0 | 52.5 ± 13.5 | 50.0 ± 13.0 | 0.96 | 0.06 |